Interestingly, PGC expression varies across cancers and is frequently upregulated in certain sex-related cancers, such as prostate, breast, and ovarian cancers, where higher levels are associated with improved prognosis [21,22,23,24]. The gene discussed is PGC; the disease is cancer.